A group of gastroenterology researchers in Italy has lost their 2010 paper in Internal and Emergency Medicine, the journal of the Italian Society of Internal Medicine, for plagiarizing and duplicate publication.
The article, “Gut microbiota and related diseases: clinical features,” was published as a supplement by a team from the University of Bologna. Its conclusions: Continue reading Mix-and-match text topples microbiome paper
The journal Neurology has issued an expression of concern for a paper linking shingles and stroke, which got press attention when it was published.
The journal’s note refers to “errors of data presentation,” which author Judith Breuer more narrowly defined as mistakes during transcription of a table. It’s unclear whether the results themselves – that herpes zoster, the virus that causes shingles, is a risk factor for stroke and other vascular problems – are being called into question.
Here’s the expression of concern for “Herpes zoster as a risk factor for stroke and TIA: A retrospective cohort study in the UK”: Continue reading Shingles-stroke connection paper earns expression of concern for “errors in data presentation”
Fuel, an Elsevier title, has pulled an article on coal pollution because the authors took much of the work from an earlier paper of theirs in another journal.
The article, “Co-firing of coal and biomass: Development of a conceptual model for ash formation prediction,” was published in September by a group from Australia and The Netherlands.
According to the notice: Continue reading Non-renewable resource: Fuel yanks paper for duplication
A Korean stem cell journal has retracted a paper on a controversial Italian treatment that involves harvesting stem cells from bone marrow and injecting them back into the patient.
“Stamina therapy” has been pitched as a treatment for everything from Parkinson’s disease to coma, based on a U.S. patent application filed in 2010. The Italian government pledged about $3.9 million in 2013 to support a clinical trial for stamina therapy. More than 100 people signed up for the trials, with a wide range of neurological ailments; half were children.
However, allegations of fraud led to a criminal investigation into the Stamina Foundation’s leader, psychologist David Vannoni, as well as 17 other members of the organization. Continue reading Paper on controversial stem cell “stamina therapy” retracted
Alfredo Fusco, a researcher in Italy under criminal investigation, now has a seventh retraction for manipulated images.
Here’s the notice for “Retraction: Identification of new high mobility group A1 associated proteins,” to which not all of the authors agreed: Continue reading Italian researcher facing criminal charges notches seventh retraction
A paper in the Journal of Clinical Investigation has been retracted for manipulated images, including duplicated bands in a Western blot.
Take a look at figure one to the right and see if you can spot all the doubles.
Click here for a more zoomable image.
Here’s the notice: Continue reading JCI lymphoma paper retracted after authors can’t find underlying data to explain duplicated bands
Ultramicroscopy has retracted a paper it published earlier this year after the corresponding author admitted to submitting the paper without the consent of his colleagues.
The article, “The post-peak spectra in electron energy loss near edge structure,” came from a group led by one Feng Tian, a materials scientist at Shanghai University for Science and Technology. The other authors were Peter Shattschneider and Micheal Stoger-Pollach, of the Vienna University of Technology. Except that they weren’t.
According to the retraction notice: Continue reading Phantom authorship forces retraction of electron paper
A 2011 paper in the Journal of Clinical Investigation whose PubPeer entry we highlighted in September has been retracted.
Here’s the notice for “Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients,” a 2011 paper by researchers at Johns Hopkins and Imperial College: Continue reading COPD paper in JCI retracted following PubPeer critiques
The Journal of Clinical Psychopharmacology has retracted a 2011 paper on depersonalization disorder by a pair of authors in Azerbaijan who got a bit too familiar with their source material without proper attribution. And the journal has offered its readers a handy — if depressingly obvious — admonition about publication ethics.
The article, “Lamotrigine in the immediate treatment of outpatients with depersonalization disorder without psychiatric comorbidity. Randomized, double-blind, placebo-controlled study,” by researchers at the Central Mental Clinic for Outpatients of Baku City, purported to find that: Continue reading Psych paper falls afoul of journal’s plagiarism policy (hint: don’t plagiarize)
Two Oxford journals have now put out three more retractions for ob-gyn and former University of Florida professor Nasser Chegini, who has been under ORI investigation since at least 2012. That makes a total of five retractions, by our count.
Here is the notice for “The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression” in Molecular Human Reproduction: Continue reading Three more retractions appear for Florida ob-gyn under investigation